These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 22399158)
1. Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact. Mitsunori Y; Tanaka S; Nakamura N; Ban D; Irie T; Noguchi N; Kudo A; Iijima H; Arii S J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):234-42. PubMed ID: 22399158 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma. Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582 [TBL] [Abstract][Full Text] [Related]
3. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma. Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294 [TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis: is it useful or useless? A prospective cohort study of our experience. Torzilli G; Palmisano A; Del Fabbro D; Marconi M; Donadon M; Spinelli A; Bianchi PP; Montorsi M Ann Surg Oncol; 2007 Apr; 14(4):1347-55. PubMed ID: 17253105 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of sonazoid-ultrasonography during hepatectomy in patients with liver tumors: A preliminary study. Nanashima A; Tobinaga S; Abo T; Kunizaki M; Takeshita H; Hidaka S; Taura N; Ichikawa T; Sawai T; Nakao K; Nagayasu T J Surg Oncol; 2011 Feb; 103(2):152-7. PubMed ID: 21259249 [TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: clinical and biological significance. Sato K; Tanaka S; Mitsunori Y; Mogushi K; Yasen M; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Tanaka H; Arii S Hepatology; 2013 Apr; 57(4):1436-47. PubMed ID: 23150500 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939 [TBL] [Abstract][Full Text] [Related]
8. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma. Luo W; Numata K; Morimoto M; Oshima T; Ueda M; Okada M; Takebayashi S; Zhou X; Tanaka K Eur J Radiol; 2010 Jul; 75(1):91-7. PubMed ID: 19361941 [TBL] [Abstract][Full Text] [Related]
9. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma. Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma. Hatanaka K; Chung H; Kudo M; Haji S; Minami Y; Maekawa K; Hayaishi S; Nagai T; Takita M; Kudo K; Ueda T; Tatsumi C; Kitai S; Ishikawa E; Yada N; Inoue T; Hagiwara S; Ueshima K Oncology; 2010 Jul; 78 Suppl 1():53-9. PubMed ID: 20616585 [TBL] [Abstract][Full Text] [Related]
11. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma. Kudo M; Hatanaka K; Maekawa K Oncology; 2010 Jul; 78 Suppl 1():40-5. PubMed ID: 20616583 [TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma. Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852 [TBL] [Abstract][Full Text] [Related]
13. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation. Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography. Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404 [TBL] [Abstract][Full Text] [Related]
15. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions. Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Zhou X; Tanaka K Eur J Radiol; 2009 Dec; 72(3):425-31. PubMed ID: 18930616 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859 [TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases. Torzilli G; Del Fabbro D; Palmisano A; Donadon M; Bianchi P; Roncalli M; Balzarini L; Montorsi M J Gastrointest Surg; 2005 Nov; 9(8):1148-53; discussion 1153-4. PubMed ID: 16269386 [TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma. Numata K; Fukuda H; Miwa H; Ishii T; Moriya S; Kondo M; Nozaki A; Morimoto M; Okada M; Takebayashi S; Maeda S; Nozawa A; Nakano M; Tanaka K Eur J Radiol; 2014 Jan; 83(1):95-102. PubMed ID: 24176532 [TBL] [Abstract][Full Text] [Related]
19. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma. Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392 [TBL] [Abstract][Full Text] [Related]
20. New contrast enhanced ultrasonography agent: impact of Sonazoid on radiofrequency ablation. Hiraoka A; Hiasa Y; Onji M; Michitaka K J Gastroenterol Hepatol; 2011 Apr; 26(4):616-8. PubMed ID: 21418298 [No Abstract] [Full Text] [Related] [Next] [New Search]